Compare CVS Health Corp (CVS) vs SoFi Technologies Inc (SOFI) Price & Performance

CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.

The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.

SoFi Technologies (SOFI) trades at $18.38, up 1.55% on the day, with a bullish technical signal from moving averages but a neutral stance from oscillators. The company reported strong Q2 2026 results, beating EPS estimates with 40% year-over-year adjusted net revenue growth and record loan originations. Revenue guidance for 2026 was raised to $4.75–$4.85 billion, though EBITDA and earnings outlooks were maintained. The stock's valuation shows a P/E of 37.51 and P/S of 5.73, reflecting growth expectations amid profitability improvements.

The outlook for SOFI is cautiously optimistic, driven by robust member growth, cross-selling success, and a diversified revenue stream. Key opportunities include continued execution on the 'everything app' strategy and potential upside to the $19.50 consensus price target. Risks involve reliance on lending growth, pressure on Technology Platform margins, and sensitivity to Federal Reserve rate decisions. Investors should weigh strong fundamentals against high valuation multiples and competitive fintech pressures.